MedTrace Logo

Epidural Analgesia and Delivery of Second Twin

NCT04608006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2020-10-30

No results posted yet for this study

Summary

Over an 8-year period, 124 twin pregnancies at gestational age ≥32 weeks with both twins presenting as a vertex and eligible for vaginal delivery were reviewed. Excluded were patients with the following intrapartum factors which may affect mode of delivery of second twin: 1. Presentation of the 2nd twin: breech or other than vertex; 2. Monochorionic twins; 3. Induction of labour; 4. difference in foetal weight between twin B and twin A ≥25%. The chi-square statistic was used to compare differences in the incidence of retained second twin between the groups.

Conditions

  • Epidural
  • Analgesia
  • Labor Pain

Interventions

DRUG

Bupivacaine-fentanyl

Initial epidural bolus of 10 ml Bupivacaine 0.125% plus 50 mcg Fentanyl, followed by continuous infusion pf Bupivacaine 0.0625%™ plus 1mcg/dl Fentanyl

Sponsors & Collaborators

  • Abdelrady S Ibrahim, MD

    lead OTHER

Principal Investigators

  • Abdelrady S Ibrahim, M.D. · Assiut University

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-03
Primary Completion
2019-12-24
Completion
2019-12-24
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04608006 on ClinicalTrials.gov